Detection of 2-Hydroxyglutarate in IDH-Mutated Glioma Patients by In Vivo Spectral-Editing and 2D Correlation Magnetic Resonance Spectroscopy
Name
Vander Heiden_Detection of 2.pdf
Size
3.08 MB
Format
Adobe PDF
Checksum (MD5)
9ef1db8d1ad9d54cc77163abcddee051
Author(s)
Andronesi, Ovidiu C.
Kim, Grace S.
Gerstner, Elizabeth R.
Batchelor, Tracy T.
Tzika, Aria A.
Fantin, Valeria R.
Vander Heiden, Matthew G.
Sorensen, A. Gregory
Date Issued
January 2012
Journal
Science Translational Medicine
Publisher
American Association for the Advancement of Science
Citation
Andronesi, O. C., et al. (2012). "Detection of 2-Hydroxyglutarate in IDH-Mutated Glioma Patients by In Vivo Spectral-Editing and 2D Correlation Magnetic Resonance Spectroscopy." Science Translational Medicine 4(116): 116ra114.
Version
Author's final manuscript
Abstract
Mutations in the gene isocitrate dehydrogenase 1 (IDH1) are present in up to 86% of grade II and III gliomas and secondary glioblastoma. Arginine 132 (R132) mutations in the enzyme IDH1 result in excess production of the metabolite 2-hydroxyglutarate (2HG), which could be used as a biomarker for this subset of gliomas. Here, we use optimized in vivo spectral-editing and two-dimensional (2D) correlation magnetic resonance spectroscopy (MRS) methods to unambiguously detect 2HG noninvasively in glioma patients with IDH1 mutations. By comparison, fitting of conventional 1D MR spectra can provide false-positive readouts owing to spectral overlap of 2HG and chemically similar brain metabolites, such as glutamate and glutamine. 2HG was also detected using 2D high-resolution magic angle spinning MRS performed ex vivo on a separate set of glioma biopsy samples. 2HG detection by in vivo or ex vivo MRS enabled detailed molecular characterization of a clinically important subset of human gliomas. This has implications for diagnosis as well as monitoring of treatments targeting mutated IDH1.
MIT Department
Massachusetts Institute of Technology. Department of Biology
Koch Institute for Integrative Cancer Research at MIT
Terms of Use
Creative Commons Attribution-Noncommercial-Share Alike
Persistent DSpace Link
DOI of Published Version
https://doi.org/10.1126/scitranslmed.3002693
